Plant Summary

  Plant Information

TCMBank_ID:

TCMBANKHE003745

YEM_ID:

YEM-786

XU_ID:

XU-643

ID:

TCMBANKHE003745/YEM-786/XU-131/XU-268/XU-643

植物拉丁名:

Erigeron breviscapus|Erigeron breviscapus(Vant.)Hand.-Mazz.|Erigeron breviscapus (Vant.) Hand. -Mazz.
显示图片

功能与主治:

To dissipate cold and resolve exterior, dispel wind and eliminate damp, quicken network vessels and relieve pain, disperse accumulation./Common cold with headache and nasal congestion, wind-damp impediment pain, paralysis, acute gastritis, child gan accumulation, knocks and falls.

药用植物名:

灯盏细辛|短葶飞蓬|短葶飞蓬(灯盏花)

药名:

灯盏花

来源:

云南民族药物志：第四卷|云南省迪庆州维西县

药用部位:

whole herb|全株

使用民族:

阿昌族/白族/傣族/德昂族/基诺族/傈僳族/苗族/彝族/藏族/壮族

KUMST_ID1:

KMUST-BS-0656

KUMST_ID2:

KMUST-2024041200070-1

TCM_ID_id:

5395

   植物对应的化合物
化合物ID 化合物名 别名 分子式 分子质量 Smiles
TCMBANKIN003632 1-o-methyl-3,5-o-dicaffeoyl quinic acid methyl ester 1-o-methyl-3,5-o-dicaffeoyl quinicacid methylester C27H28O12 CCOC(=O)C1(CC(C(C(C1)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O
TCMBANKIN018423 5 '-O-demethylhamatintine
TCMBANKIN033428 1-hydroxy-2, 3, 5-trimethoxyxanthone 1-Htmx; 1-hydroxy-2,3,5-trimethoxy-9-xanthenone; 1-hydroxy-2,3,5-trimethoxyxanthen-9-one; 1-Hydroxy-2,3,5-trimethoxyxanthene; 9H-Xanthen-9-one, 1-hydroxy-2,3,5-trimethoxy-; 1-Hydroxy-2,3,5-trimethoxyxanthone; 1-hydroxy-2,3,5-trimethoxyxanthone; 22804-49-5; 1-hydroxy-2,3,5-trimethoxy-xanthen-9-one; Xanthone, 1-hydroxy-2,3,5-trimethoxy-; 1-hydroxy-2,3,5-trimethoxy-xanthone; 1-Hydroxy-2,3,5-trimethoxy xanthone C16H14O6 302.28 COC1=CC=CC2=C1OC3=CC(=C(C(=C3C2)O)OC)OC
TCMBANKIN036149 Catharanthamine catharanthamine C46H56N4O9 808.96 CCC12CC3CN(C1)CCC4=C(C(C3O2)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)NC1=CC=CC=C41
TCMBANKIN036894 scutellarin (2S,3S,4S,5R,6S)-6-[[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-7-chromenyl]oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; CHEBI:61284; 676536-34-8; 1329-06-2; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-D-glucopyranuronoside; scutellarin(1-); scutellarein 7-O-beta-D-glucuronate; Scutellarein-7beta-D-glucuronide; AIDS-314104; AIDS314104; 32647-60-2; Scutellarein-7-O-beta-D-glucuronide; Scutellarein-7-glucuronide; Breviscapine; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 116122-36-2; Breviscapin; MEGxp0_000554; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl; Glucopyranosiduronic acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, beta-D-; Scutellarin; Scutellarein-7beta-D-glucuronoside; 27740-01-8; 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranosiduronate; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid C21H18O12 462.4 g/mol C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O
TCMBANKIN039565 Methyl 4,6-di-O-galloyl-beta-D-glucopyranoside [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxyphenyl)carbonyloxymethyl]oxan-3-yl] 3,4,5-trihydroxybenzoate; 3,4,5-trihydroxybenzoic acid [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-3-yl] ester; 3,4,5-trihydroxybenzoic acid [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[[oxo-(3,4,5-trihydroxyphenyl)methoxy]methyl]-3-tetrahydropyranyl] ester; [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]tetrahydropyran-3-yl] 3,4,5-trihydroxybenzoate; [(2R,3S,4R,5R,6R)-4,5-dihydroxy-6-methoxy-2-[(3,4,5-trihydroxybenzoyl)oxymethyl]oxan-3-yl] 3,4,5-trihydroxybenzoate; methyl 4,6-di-o-galloyl-beta-d-glucopyranoside; methyl 4,6-di-o-galloyl-β-d-glucopyranoside C21H22O14 498.391 c1(O[H])c([H])c(C(OC([H])([H])[C@]([H])([C@@]([H])(OC(=O)c2c([H])c(O[H])c(O[H])c(O[H])c2[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]3([H])OC([H])([H])[H])O3)=O)c([H])c(O[H])c1O[H]
TCMBANKIN041092 Breviscapine 462.4 g/mol
TCMBANKIN043001 5,6,7,3',4',5'-Hexamethoxyflavone 402.4 g/mol
TCMBANKIN045668 Apigenin-4'-O-glucuronide
TCMBANKIN058121 6'-o-caffeoylerigeroside 1-(2'-γ-pyranone)-6-caffeoyl-α-d-pyranoglucose C20H20O11 436.4 g/mol C1=CC(=C(C=C1C=CC(=O)OCC2C(C(C(C(O2)OC3=COC=CC3=O)O)O)O)O)O
TCMBANKIN058220 breviscapine 5,6,4'-trihydroxyflavone-7-o-beta-d-galactonic acid;scutellarin;5,6,4'-trihydroxyflavone-7-o-β-d-galactonicacid;(2S,3S,4S,5R,6S)-6-[[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-7-chromenyl]oxy]-3,4,5-trihydroxy-2-tetrahydropyrancarboxylic acid; CHEBI:61284; 676536-34-8; 1329-06-2; 4H-1-Benzopyran-4-one, 7-(.beta.-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-; Flavone, 4',5,6,7-tetrahydroxy-, 7-beta-D-glucopyranuronoside; scutellarin(1-); scutellarein 7-O-beta-D-glucuronate; Scutellarein-7beta-D-glucuronide; AIDS-314104; AIDS314104; 32647-60-2; Scutellarein-7-O-beta-D-glucuronide; Scutellarein-7-glucuronide; Breviscapine; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid; 116122-36-2; Breviscapin; MEGxp0_000554; beta-D-Glucopyranosiduronic acid, 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl; Glucopyranosiduronic acid, 5,6-dihydroxy-2-(p-hydroxyphenyl)-4-oxo-4H-1-benzopyran-7-yl, beta-D-; Scutellarin; Scutellarein-7beta-D-glucuronoside; 27740-01-8; 5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl beta-D-glucopyranosiduronate; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-keto-chromen-7-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid; (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-chromen-7-yl]oxy-3,4,5-trihydroxy-oxane-2-carboxylic acid C21H18O12 462.4 g/mol C1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O
TCMBANKIN058288 catechol 430749_ALDRICH; Catechin (phenol); Pyrokatechin [Czech]; NCGC00015283-01; Catechol-UL-14C; NCI-C55856; CI Oxidation Base 26; CHEBI:18135; benzene-1,2-diol; C15571; 120-80-9; InChI=1/C6H6O2/c7-5-3-1-2-4-6(5)8/h1-4,7-8; C9510_SIAL; Fouramine PCH; 135011_SIAL; Lopac-C-9510; 2-hydroxyphenol; NSC 1573; NCGC00091262-01; Fourrine 68; o-Diphenol; C.I. Oxidation Base 26; o-Dioxybenzene; C00090; ST5214346; (1,2,3,4,5,6-(1)?C?)BENZENE-1,2-DIOL; AB-131/40235236; Lopac0_000280; ortho-Benzenediol; Catechol (phenol); ortho-Hydroquinone; ZINC00330145; 16474-90-1; pyrocatechol; benzenediol; Brenzcatechin; 12385-08-9; C01785; EINECS 204-427-5; EU-0100280; nchembio801-comp10; o-Dihydroxybenzene; Durafur Developer CFouramine PCH; o-Hydroxyphenol; Phthalhydroquinone; 16474-89-8; Catechol-pyrocatechol; CCRIS 741; ACM19481108; AI3-03995; Pyrocatechinic acid; CI 76500; Durafur developer C; o-Phenylenediol; 1,2-dihydroxybenzene; ortho-Hydroxyphenol; Oxyphenic acid; BRN 0471401; c0097; pyrocatechol-ul-14C; CAQ; 37349-32-9; ortho-Dihydroxybenzene; AIDS-108194; C3561_SIAL; o-Benzenediol; ortho-Dioxybenzene; Katechol [Czech]; Pelagol Grey C; Pyrokatechol [Czech]; AIDS108194; Pyrocatechinic acidPyrocatechol; WLN: QR BQ; Pyrocatechine; 1,2-benzenediol; o-Hydroquinone; CATECHOL; Benzene, o-dihydroxy-; pyrocatechin; ortho-Phenylenediol; HSDB 1436; C9593_SIGMA; NSC1573; C.I. 76500;pyrocatechol;o-hydroquinone;o-phenylenediol;1,2-benzenediol C6H6O2 110.11 g/mol C1=CC=C(C(=C1)O)O
TCMBANKIN061521 Scutevulin 80713-32-2; 2',5,7-Trihydroxy-8-methoxyflavone; SCHEMBL5162875; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-chromen-4-one; scutevulin; CHEMBL2235250; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-4-chromenone; 5,7,2'-trihydroxy-8-methoxyflavone; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxychromen-4-one; LMPK12111303; AC1NT0AX; 5,7-dihydroxy-2-(2-hydroxyphenyl)-8-methoxy-chromone C16H12O6 300.26 COC1=C(C=C(C2=C1OC(=CC2=O)C3=CC=CC=C3O)O)O
TCMBANKIN061667 5,7,4'-trihydroxy-6-methoxyflavanone 6-Methoxynaringenin;5,7,4'-trihydroxy-8-methoxyflavanone;AC1NT16C; 5,7,4/'-Trihydroxy-6-methoxyflavanone; AK104440; 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6-METHOXY-2,3-DIHYDRO-1-BENZOPYRAN-4-ONE; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxychroman-4-one; AKOS022184707; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-2,3-dihydrochromen-4-one; 5,7,4'-trihydroxy-6-methoxydihydroflavone; 6-Methoxynaringenin; 4CN-1869; 5,7-dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-3,4-dihydro-2H-1-benzopyran-4-one; ST24044117; W1586; 5,7,4'-Trihydroxy-6-methoxyflavanone; 94942-49-1; LMPK12140619 C16H14O6 302.28 g/mol COC1=C(C2=C(C=C1O)OC(CC2=O)C3=CC=C(C=C3)O)O
   植物对应的疾病
疾病ID 病名 疾病类型 MeSH 参考文献
TCMBANKDI000083 Infarction, Middle Cerebral Artery disease Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases 25600517
TCMBANKDI000084 Platelet aggregation phenotype - 23350663
   植物对应的靶点
靶点ID 基因名 基因别名 描述 染色体位置 Map_Location 基因类型
TCMBANKGE000903 PTGS1 COX1; COX3; PCOX1; PES-1; PGG/HS; PGHS-1; PGHS1; PHS1; PTGHS prostaglandin-endoperoxide synthase 1 9 9q33.2 protein-coding
TCMBANKGE001073 PTGS2 COX-2; COX2; GRIPGHS; PGG/HS; PGHS-2; PHS-2; hCox-2 prostaglandin-endoperoxide synthase 2 1 1q31.1 protein-coding

Home | Browse | Search | Predict | Data | Contact | Help

Copyright © KUST | 滇ICP备16009434号-1 | Dai SX Lab